跳至主要内容
临床试验/ACTRN12616001528448
ACTRN12616001528448已完成未知

A pilot trial on the short term effects of leucine supplementation during weight loss, on body composition, insulin sensitivity and metabolic flexibility in the metabolic syndrome.

A/Prof. Mario Soares0 个研究点目标入组 34 人开始时间: 2016年11月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 65 Years(—)
性别
All

入选标准

  • Adult Australian men and women with abdominal obesity and at least one other criteria for MetS as judged by recent consensus guidelines (Alberti et al, 2009), aged 20- 65 years, of European origin, Not on calcium or vitamin supplements. Medications like lipid lowering therapy and hypertension will be quantified and monitored.

排除标准

  • any history of MI, stroke, T1DM or weight loss in previous 6 months,on medication that affects body composition, energy expenditure or food intake will be excluded

研究者

发起方
A/Prof. Mario Soares

相似试验